Views 142
Citations 0
Editor's Correspondence
Nov 12, 2012

Drug-Eluting Stents Should Not Be Used in ST-Elevated Myocardial Infarction With Cardiogenic Shock

Author Affiliations

Author Affiliations: Service de Réanimation Polyvalente, Centre Hospitalier Universitaire de La Réunion, Saint Denis, France.

Arch Intern Med. 2012;172(20):1613-1614. doi:10.1001/archinternmed.2012.4418

De Luca and colleagues1 concluded from their meta-analysis that drug-eluting stents (DES) in the ST-elevated myocardial infarction (STEMI) setting are more efficient than bare-metal stents (BMS) in reducing target-vessel revascularization (TVR). One must remember that during STEMI, one of the most serious complications is cardiogenic shock, which is not well pinpointed in their study.

First Page Preview View Large
First page PDF preview
First page PDF preview